Skip to content
S9040Senate2023-2024 SessionSame asA9764

Protect Pharmacy Price Disclosure

Official title

“Relates to prohibited practices of pharmacy benefit managers”

Sponsor Andrew GounardesSD-26+2 co-sponsorsAffects Health
Status
Signed by Governor
Impact
6/10
Moderate
Outcome
Signed into law

Bill progress

Signed into law

What's happening

This bill prohibits pharmacy benefit managers from penalizing pharmacies for sharing cost and reimbursement information about prescription medications or services with customers.

Why it matters

  1. Empowers pharmacies to be more transparent with customers. by explicitly allowing them to share not only the retail cost, but also the price the pharmacy pays and the reimbursement it receives for prescription medications or services. This could help consumers better understand pricing and potential mark-ups.

  2. Could increase consumer ability to shop for better prices. by requiring that pharmacies can disclose information about alternative, therapeutically equivalent medications and different ways to purchase (such as paying cash), which can sometimes be cheaper than insurance copays.

  3. Limits pharmacy benefit managers’ (PBMs) ability to set anti-consumer contract terms. , potentially reducing practices that keep consumers from accessing cost-saving information or alternatives, and preventing PBMs from penalizing pharmacies for transparency.

  4. Addresses concerns about overcharging and 'clawback' practices. by ensuring pharmacies cannot be forced to charge patients copays higher than the pharmacy’s actual costs, and by preventing PBMs from recouping those extra amounts, which could lower out-of-pocket costs for customers.

The daily · weekday mornings

Albany, before your first meeting.

Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.

Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.

Headline styles

Protect Pharmacy Price Disclosure

Plain English, a few words. Used as the page title.

Sponsors

Primary sponsor
Andrew Gounardes

Senator · Senate District 26

Chair, Budget And Revenue

History

  1. Signed chap.396
  2. Delivered to governor
  3. Returned to senate
  4. Passed assembly
  5. Ordered to third reading rules cal.119
  6. Substituted for A9764
  7. Referred to health
  8. Delivered to assembly
  9. Passed senateVote 58–1
  10. Ordered to third reading cal.1776
  11. Committee discharged and committed to rules
  12. Referred to health

Companion bill

The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.

A9764Assembly

Let Pharmacies Share Drug Costs

Assembly Floor Calendar · Sponsor Linda Rosenthal

Impact 7 · Significant0% to pass

Full text

1 pageUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗

STATE OF NEW YORK

9040

IN SENATE

April 11, 2024

Introduced by Sen. GOUNARDES -- read twice and ordered printed, and when printed to be committed to the Committee on Health

AN ACT to amend the public health law, in relation to prohibiting pharmacy benefit managers from penalizing pharmacies for providing customers certain information relating to the costs of prescription medications

The People of the State of New York, represented in Senate and Assembly, do enact as follows:

Section 1. Subdivision 5 of section 280-a of the public health law, as amended by chapter 128 of the laws of 2022, is amended to read as follows:

5. Contract provisions. No pharmacy benefit manager shall, with respect to contracts between such pharmacy benefit manager and a pharmacy or, alternatively, such pharmacy benefit manager and a pharmacy's contracting agent, such as a pharmacy services administrative organization:

(a) prohibit or penalize a pharmacist or pharmacy from disclosing to an individual purchasing a prescription medication or service information regarding:

(i) the cost of the prescription medication or service to the individual, or the cost of the prescription medication or service to the pharmacy and the pharmacy's reimbursement for that prescription medication or service; or

(ii) the availability of any therapeutically equivalent alternative medications or alternative methods of purchasing the prescription medication, including but not limited to, paying a cash price; or

(b) charge or collect from an individual a copayment that exceeds the total submitted charges by the pharmacy for which the pharmacy is paid. If an individual pays a copayment, the pharmacy shall retain the adjudicated costs and the pharmacy benefit manager shall not redact or recoup the adjudicated cost.

§ 2. This act shall take effect immediately.

EXPLANATION--Matter in italics (underscored) is new; matter in brackets

[ ] is old law to be omitted.

LBD14486-03-4

Reflowed for reading: line numbers and page breaks removed. Cite the official text.

Sponsor's memo

Title of bill

An act to amend the public health law, in relation to prohibiting phar- macy benefit managers from penalizing pharmacies for providing customers certain information relating to the costs of prescription medications

Purpose or general idea of bill

To allow pharmacies to disclose prescription drug costs and reimburse- ment rates.

Summary of provisions

Section one of this bill amends subdivision five of section 280-a of Public Health Law to allow pharmacists to discuss the cost of a patient's medication of service to the pharmacy from a manufacturer or pharmacy benefit manager with said patient.

Section two sets the effective date.

Justification

In 2018, New York State enacted a law to prevent pharmacy benefit manag- ers (PBMs) from penalizing pharmacies that inform customers when a prescription will be cheaper out-of-pocket instead of being run through their insurance. This law took the first step to removing the "gag clause" for pharmacists by ensuring that they could also discuss copays, the availability of therapeutically equivalent alternative medications, or alternative methods of procuring a medication with their patients. These changes helped ensure greater transparency while also allowing patients to receive the lowest cost for their medication.

This bill builds upon the prior reform by further improving the "gag clause" in Section 280-a of Public Health Law to provide that pharma- cists can also discuss the pharmacy's own reimbursement rates on a patient's medication or services. The reasoning for this change is that, under current law, pharmacists cannot tell a patient that a particular drug or service will result in a negative reimbursement for a pharmacy, despite the fact that such reimbursement is likely the reason that the pharmacist is not able to stock the patient's medication. This leads to a patient access problem for customers who are left none the wiser about why they can't procure a needed medication.

This is not the case in other industries or sectors, however. A store selling electronic consumer goods, for example, is allowed to tell its customers that a manufacturer charges too much for a given television for it to make economic sense for the store to stock it.

A 2024 report by the Community Oncology Alliance found that PBMs routinely reimburse pharmacies below the cost of doing business, endan- gering their ability to provide proper care and lifesaving medications to the communities they serve. To ensure pharmacies, particularly small and independent pharmacies, can continue to operate, it is imperative that greater transparency measures are in place. This legislation would further protect pharmacies from penalties imposed by PBMs for discussing prescription drug costs to the pharmacy and their reimbursement rates.

Prior legislative history

None

Fiscal implications

None

Effective date

Immediate

Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.